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Amla(PhyllanthusemblicaL.),apartfromitsfoodvalue,canbeusedasagastroprotectiveagentinnonsteroidalanti-inﬂammatory
drug (NSAID)-induced gastropathy. It has been suggested that the antioxidative property of amla is the key to its therapeutic
eﬀect. Hence, on the basis of in vitro antioxidative potential, the ethanolic extract of amla (eAE) was selected for in vivo study
in NSAID-induced ulcer. Intriguingly, eAE showed biphasic activity in ulcerated mice, with healing eﬀect observed at 60mg/kg
and an adverse eﬀect at 120mg/kg.The dose-dependent study revealed that switching from anti-oxidant to pro-oxidant shift
and immunomodulatory property could be the major cause for its biphasic eﬀect, as evident from the total antioxidant status,
thiol concentration, lipid peroxidation, protein carbonyl content followed by mucin content, PGE2 synthesis and cytokine status.
Further, Buthionine sulfoxamine (BSO) pretreatment established the potential impact of antioxidative property in the healing
action of eAE. However, eAE eﬃciently reduced pro-inﬂammatory cytokine (TNF-α and IL-1β) levels and appreciably upregulate
anti-inﬂammatory cytokine (IL-10) concentration. In conclusion, gastric ulcer healing induced by eAE was driven in a dose-
speciﬁc manner through the harmonization of the antioxidative property and modulation of anti-inﬂammatory cytokine level.
1.Introduction
Phyllanthus emblica L. or Emblica oﬃcinalis Gaertn, also
known as Indian gooseberry, is a medium-sized deciduous
tree of the Euphorbiaceae family. The fruits of P.emblica L.
known as amla, are consumed as fruit, or in the form of
food products. The species is native to India and also grows
in tropical and subtropical regions. It primarily contains
tannins, alkaloids, and phenolic compounds, but ﬂavonoids
derived from amla shows maximum beneﬁcial in medicinal
aspect. Ayurveda and Siddha systems of medicine have
recognized the importance of this plant. It is one of the
strongest rejuvenatives among Indian medicinal plants due
to its antimicrobial [1, 2], antifungal [3], radioprotective
[4], chondroprotective [5], antimutagenic, and anticancer
properties [6, 7], but its most extraordinary features are its
anti-inﬂammatory [3] and antioxidative properties [8]. A
clinical study has also found that amla showed signiﬁcant
healing eﬀect on gastric syndrome [9].
Among the total gastric ulcer patients, twenty-ﬁve
percents suﬀer from acute drug-induced gastric ulceration
[10, 11], a major example of which is gastric ulceration
induced by non-steroidal anti-inﬂammatory drugs (NSAID)
such as indomethacin. This kind of ulceration involves
oxidative stress. The balance between proinﬂammatory and
anti-inﬂammatory cytokines plays also an important role
in various diseases. An imbalance in favour of the pro-
inﬂammatory cytokines interleukin-1β or tumour necrosis
factor-α has been implicated in the pathogenesis of diﬀerent
diseases including ulcerative colitis [12]. In addition, anti-
inﬂammatory cytokines exert protective eﬀects in experi-
mental models of sepsis, rheumatoid arthritis, and autoim-
mune diabetes [13]. The present study highlighted that the
balance of the pro- and anti-inﬂammatory cytokines could
playalsoasigniﬁcantroleinNSAID-inducedgastricmucosal
injury.
Treatmentwithindomethacincansubstantiallyanddras-
tically induce proinﬂammatory cytokine IL-1β and TNF-α2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Histology of mouse gastric tissue after ulcer induction by indomethacin and the eﬀect of eAE. Ulceration in mice was induced by
indomethacin (18mg /kg, p.o.). eAE at diﬀerent doses (40mg/kg, 60mg /kg, and 120mg/kg) and Omeprazole (3mg/kg) were administered
6h post ulcer induction as described in Section 2. At the third day of ulceration, mice were sacriﬁced, and the stomachs were sectioned for
the histological studies. Histological photograph of sham-treated (a), ulcerated untreated (b), eAE-(40mg /kg) treated (c), eAE-(60mg /kg)
treated (d), eAE-(120mg /kg) treated (e), and omeprazole-(f) treated mice stomach section stained with hematoxylin and eosin, present
here. Gastric tissue sections were photographed at a 40X magniﬁcation. Mucosal and submucosal layers are shown by blue and green arrows,
respectively.
levels, thus shifting the cytokine balance to the proinﬂam-
matory end, resulting in gastric ulceration. Amla extract
(AE), however, has already proved itself a potent antioxidant,
and diﬀerent reports have claimed that its antioxidative
property is signiﬁcantly immunomodulatory [14]; hence, we
examined the eﬀect of AE on these parameters in the light of
gastric ulcer healing.
2.MaterialsandMethods
2.1.Materials. Fruits of PhyllanthusemblicaL.werecollected
from the local market and identiﬁed by the Botanical Survey
of India (Ref. no. BSI /CNH/AD/Tech./2009).
2.2. Chemicals and Reagent. Indomethacin, thioberbituric
acid (2-TBA), triﬂuro aceteic acid (TFA), omeprazole,
5-bromo-4-chloro-3-indolyl phosphate (BCIP), nitroblue
tetrazolium (NBT), Tween-20, Bradford, buthionine sulfox-
amine (BSO), 1,1-diphenyl-2-picrylhydrazyl (DPPH), 5,5 -
dithiobis-2-nitrobenzioc acid (DTNB), hexadecyl trimethyl
Table 1: In vitro antioxidative assay.
Test sample Concentration (μg/mL)
Alpha tocopherol 25.98 ± 1.482
Ethanolic amla extract 3.0
∗∗∗, ##, ΨΨΨ± 0.50
Methanolic amla extract 6.0
∗∗∗± 1.5
Hot water amla extract 15.67
∗∗∗± 1.528
IC50 values (μg/mL) of test samples in scavenging of DPPH radical. Values
are mean ± standard deviations (S.D.) (n = 3). ∗∗∗P<. 001 when
compared to the standard alpha tocopherol, ##P<. 01 when compared to
themethanolicamlaextract, ΨΨΨP<. 001whencomparedtothehotwater
amla extract.
ammonium bromide (HTAB), and anti-dinitrophenyl (anti-
DNP) antibody were purchased from Sigma-Aldrich Chem-
ical Co, MO, St. Louis, USA. ethanol and methanol
from E. Merck, Mumbai, India; bovine serum albumin
(BSA), hematoxylin monohydrate, and eosin yellowish from
Merck, Darmstadt, Germany; dimethylformamide (DMF)Evidence-Based Complementary and Alternative Medicine 3
and tetramethyl benzidine (TMB) from Acros, Geel, Bel-
gium; Prostaglandin E2 EIA kit and Total Antioxidant
Status-Assay kit from Cayman Chemical; Cytokines TNF-
α,I L - 1 β, and IL-10 ELISA kit from Pierce Biotechnology,
Rockford, USA. Other reagents used were 35% hydrogen
peroxide(H2O2)fromLancaster,Morecambe,UK;disodium
hydrogen phosphate and sodium dihydrogen phosphate
from BDH, Poole, Dorset, UK; Ecoline ALAT (GPT), Ecoline
alkaline phosphatase, serum albumin, and bilirubin assay
kits from Merck; serum glutamic oxaloacetic transaminase
(aspartate aminotransferase) from Bayer AG, Wuppertal,
Germany. All other chemicals used were of the highest purity
available.
2.3. Animals. Male Swiss albino mice (6–8 weeks, 25 ± 2g)
bred in-house with free access to food and water were used
for all of the experiments. The mice were kept in 12-h
light/dark cycles and housed at 25
◦C ± 1◦C. The animal
experiments (n = 8) were conducted in accordance with
the guidelines of the animal ethics committee of the Post-
graduateInstituteofBasicMedicalSciences,Kolkata,Animal
Ethical Committee, Sanction no. IAEC/SB-3/2008/UCM-
64 Dated-15/05/08-2011 and were handled following the
InternationalAnimalEthicsCommitteeGuidelines,ensuring
minimum animal suﬀering.
2.4. In Vitro Antioxidant Assay. DPPH (1-diphenyl-2-
picrylhydrazyl) free radical scavenging assay.
An ethanolic solution of DPPH (100μM) was incubated
with an ethanolic solution of each of the test samples at
various concentrations, and the absorbance was monitored
spectrophotometrically at 517nm. The 50% reduction of
DPPH absorbance at the given concentration of the test
samples was used to calculate the IC50 values [15]. The
respective ethanol solutions of the test samples were used as
the blank, while α-tocopherol was the positive control.
2.5. Drug Treatment. The ethanolic crude extract of amla
and omeprazole [11] were prepared by using aqueous 2%
gum acacia (gum acacia used as a vehicle) and were adminis-
tered to the mice orally. In some cases, after ulcer induction,
the mice were additionally treated intraperitoneally with
BSO twice daily (ﬁrst dose at a concentration of 5mM was
administered 4h before drug treatment and the second dose
of BSO at the same concentration was administered 3h after
the ﬁrst dose).
2.6. Experimental Protocol for Ulceration and Assessment of
Healing. Acute gastric ulceration in mice was induced by
oral administration of indomethacin (18mg/kg, single dose)
dissolved in distilled water and suspended in 2% gum acacia
as vehicle [16] .T h ea n i m a l sw e r ed e p r i v e do ff o o db u t
had free access to tap water 24h, before ulcer induction.
The normal and untreated control groups received the
vehicle only throughout the course of the experiments. The
treatment groups received diﬀerent doses of amla crude
extract (once daily) and omeprazole [3mg/kg, once daily]
[11] as positive control for diﬀerent periods, with the ﬁrst
dose started 6h after indomethacin administration. On the
1st, 2nd, 3rd, 4th, and 7th day the mice were sacriﬁced by
cervical dislocation under anesthesia (ketamine, 12mg/kg).
The stomachs from the normal and treated groups were
removed rapidly, opened along the greater curvature, and
thoroughly rinsed with normal saline
2.7. Histological Analysis. The fundic stomach was sectioned
for histological studies as well as damage score analy-
sis. The tissue samples were ﬁxed in 10% formalin and
embedded in paraﬃn. The sections (5μm) were cut using
microtome, stained with hematoxylin and eosin [17]a n d
assessed under an Olympus microscope (BX41, Hamburg,
Germany). The damage score (DS) was assessed [17]b y
grading the gastric injury on a 0–4 scale, based on the
severity of hyperemia and hemorrhagic erosions: 0-almost
normal mucosa, 0.5-hyperemia, 1-one or two lesions, 2-
severe lesions, 3-very severe lesions, and 4-mucosa full of
lesions (lesions-hemorrhagic erosions, hyperemia-vascular
congestions). The sum of the total scores divided by the
number of animals is expressed as the mean damage
score. The experiments were performed by two investigators
blinded to the groups and the treatment of animals.
2.8.MyeloperoxidaseAssay. Myeloperoxidase(MPO)activity
was determined following a reported method [18]w i t h
minor modiﬁcations. Whole gastric glandular portions of
the stomach taken from all groups (100–150mg) were
homogenized in a 50mM phosphate buﬀer (pH 6.0) con-
taining 0.5% HTAB. This was followed by three cycles of
freeze and thawing. The homogenate was centrifuged at
12000 × gf o r2 0m i na t4 ◦C. The supernatant (50μL) was
collected for MPO assay and added to 80mM phosphate
buﬀer, pH 5.4, 30mM TMB and 300mM H2O2,t om a k e
a ﬁnal reaction volume of 500μL. After the mixture was
incubated at 25
◦C for 25min, the reaction was terminated
by adding 500mM H2SO4 and the change in the absorbance
was measured at 450nm. Results were expressed as total
number of neutrophils by comparing the optical density
(OD) of tissue supernatant with the OD of mice peritoneal
neutrophils processed in the same way.
A standard curve relating neutrophil numbers and
absorbance was obtained by processing puriﬁed neutrophils
and assaying the MPO activity with 0.0005% hydrogen
peroxide as the substrate. The correlation between the
number of neutrophils and units of MPO was determined
using a reported technique [19]. One unit of MPO activity
is deﬁned as that converting 1μmol of hydrogen peroxide to
w a t e ri n1m i na t2 2
◦C.
2.9. Assay of the Total Antioxidant Status in Serum. Total
antioxidants were measured by the ABTS method using kits
from CAYMAN as per manufacturer’s instructions metmyo-
globin (peroxidase) present in the chromogen provided in
the kit reacts with H2O2 to form ferrylmyoglobin, a free
radical species.The chromogen also contains ABTS (2,2
 -
amino-di-[3-ethylbenzthiazoline sulphonate]) which reacts
with ferrylmyoglobin to produce a radical cation which has4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of eAE at diﬀerent doses (40mg/kg, 60mg/kg, and 120mg/kg) on oxidative stress in NSAID-induced ulcer. Serum TAS (a),
tissue total thiol (b), tissue MDA analysis (c), and tissue protein carbonyl (d) were carried out on 3rd day of ulceration, as described under
Section 2. The values are mean S.D. ± (n = 8). ∗P>. 05, ∗∗P<. 05, ∗∗∗P<. 01, and ∗∗∗∗P< . 001.
blue-green colour and can be measured at 600nm. Antiox-
idants present in the added serum cause suppression of this
colour production proportional to their concentration. Cal-
ibration of the assay was done using 6-hydroxy-2,5,8-tetra-
methylchroman-2-carboxylic acid (trolox) equivalent.20μl
sample and 1ml of chromogen were required for the assay.
TAS was obtained using the formulae: TAS = factor
× (absorbance of blank−absorbance of sample) mmol/l;
factor = concentration of standard/(absorbance of blank-
absorbance of standard).[20]
2.10. Thiol Groups Assay. The thiol groups’ (TSH) content
wasmeasuredbythemethodsoriginallydescribedbyEllman
[21]andmodiﬁedbyHabeeb[22]withminormodiﬁcations.
Whole gastric glandular portions of the stomach taken
from all groups were homogenized in ice-cold phosphate
buﬀe r( p H8 . 0 ) .T h eti s s u eh o m o g e n a t ew a st h e nc e n tri f u g e d
for 10min at 3000rpm and the supernatant was collected
for experiment. The supernatant (100μL) was added to a
system containing 50mM phosphate buﬀer, pH 7.4, protein
dissolving solution and DTNB (0.1mL, 10mM) and was
incubated for 15min. The absorbance of the chromogen at
412nm was read.
2.11. Assay of Lipid Peroxides. The extent of lipid perox-
idation in tissue samples during in vitro incubation was
measured by quantitating the amount of malondialdehyde
(MDA) formed by 2-TBA reaction [23]. The amount of
malondialdehyde produced was calculated using the molar
extinction coeﬃcient of MDA-TBA adduct as 1.56 ×
105 cm2mmol−1 [24].Evidence-Based Complementary and Alternative Medicine 5
Table 2: eAE on ulcer index.
Groups Ulcer index (damage score) days of ulceration
12347
Sham treated 0.00 0.00 0.00 0.00 0.00
Ulcerated untreated 1.667
∗, # ,h,j± 0.577 2.33
∗, #,h,j± 0.577 3.33
∗, # ,h,j± 0.58 3.0
∗, #,h,j± 1.0 1.3
∗, #,h,j± 0.58
eAE (120mg/kg) 2.0 ± 0.00 3.0 ± 1.00 4.0 ± 0.00 3.667 ± 0.58 2.667 ± 0.577
eAE (100mg/kg) 1.667 ± 0.577 2.667 ± 0.574 3.67 ± 0.58 3.33 ± 0.577 2.33 ± 0.5774
eAE (80mg/kg) 1.333 ± 0.577 2.0 ± 0.00 3.0 ± 1.0 2.67 ± 0.58 1.667 ± 0.58
eAE (70mg/kg) 0.667a± 0.289 1.33a± 0.58 1.33aaa± 0.60 1.0a± 0.00 0.667a± 0.289
eAE (60mg/kg) 0.667a, ##± 0.29 .816aaa,####±0.764 0.83aaaa,####±0.28 0.667aa,###±0.289 0.5a, ###± 0.00
eAE (50mg/kg) 1.333a± 0.577 1.667a ± 0.58 2.67a ± 0.574 2.33a± 1.155 1.67a± 0.577
eAE (40mg/kg) 1.7a ± 0.58 2.33a ± 0.58 3.3a± 0.60 3.3a ± 0.68 2.4a ± 0.577
Omeprazole (3mg/kg) 0.833 ± 0.288 1.33 ± 0.60 2.33 ±0.58 2.0±1.0 1.667 ± 0.1638
The values are mean (n = 8) and (±) indicates S.D..∗P<. 001 when compared to the ShamTreated; aP>. 05, aaP<. 05, aaaP<. 01, aaaaP<. 001 when
compared to ulcerated untreated; #P>. 05, ##P<. 05, ###P<. 01, ####P<. 001 when compared to eAE (120mg/kg); hP>. 05 when compared to eAE
(100mg/kg); jP>. 05 when compared to eAE (80mg/kg) treated group.
Table 3 :e A Eo nM P Oa c t i v i t y .
Groups MPO activity (U/mg) days of ulceration
1 234 7
Sham treated 0.0153±0.003 0.0143 ± 0.005 0.0217 ± 0.003 0.021 ± 0.004 0.0224 ± 0.004
Ulcerated untreated 1.1454
∗,b,f,g±0.074 1.8849
∗,b,f,ggg± 0.061 2.7606
∗,bb,ﬀ,ggg± 0.047 2.6111
∗,bb,ﬀ,gg±
0.18 1.7655
∗,bb,ﬀ,g± 0.164e
eAE (120mg/kg) 1.2417 ± 0.049 1.9407 ± 0.039 3.7863 ± 0.334 3.783 ± 0.313 3.6187 ± 0.042
eAE (100mg/kg) 1.0868 ± 0.047 1.8523 ± 0.079 3.8357 ± 0.049 3.77 ± 0.119 2.9305 ± 0.036
eAE (80mg/kg) 1.0825 ± 0.052 1.5424 ± 0.056 2.1369 ± 0.097 2.0766 ± 0.045 1.817 ± 0.045
eAE (70mg/kg) 1.0079 ± 0.005 1.2408 ± 0.048 1.92 ± 0.031 1.853 ± 0.033 1.166 ± 0.047
eAE (60mg/kg) 0.7585aaa,bb± 0.031 1.0599aaa,bb± 0.008 1.5363aaa,bb± 0.027 1.45aaa,bb± 0.053 0.8439aaa,bb± 0.038
eAE (50mg/kg) 1.0223aa± 0.006 1.6236aaa± 0.017 2.3861aa± 0.009 2.3069a± 0.009 1.5302aa± 0.051
eAE (40mg/kg) 1.0623a±0.038 1.5827aaa± 0.047 2.7629a± 0.015 2.7488a± 0.036 1.8709a± 0.081
Omeprazole (3mg/kg) 1.0285 ± 0.008 1.3929 ± 0.009 1.9145 ± 0.029 1.755 ± 0.062 1.0359 ± 0.014
The values are mean (n = 8) and (±) indicates S.D. ∗P<. 001 when compared to the Sham Treated; aP>. 05, aaP<. 05, aaaP<. 001 when compared to
ulcerated untreated; bP>. 05, bbP<. 001 whencompared to eAE (120mg/kg); fP>. 05, ﬀP<. 001 when compared to eAE (100mg/kg); gP>. 05, ggP<. 05,
gggP<. 001 when compared to eAE (80mg/kg) treated group.
2.12.EstimationofProteinCarbonyl. Theglandularstomach
tissues from ﬁve animals were pooled, rinsed with appropri-
ate buﬀer, and used for biochemical studies. The wet weight
ofthetissueswasrecorded,andexperimentswerecarriedout
in triplicate. Glandular portions from the control, ulcerated
and drug-treated mice taken at diﬀerent time intervals were
homogenized with a glass-Teﬂon homogenizing tube in
50mM phosphate buﬀer (pH 7.4) and centrifuged at 1200
× g to obtain the supernatant.
The amount of protein carbonyls in the tissue
homogenate was determined using the following method
[25]. DNPH (4mL,10mM) in 2M HCl was added to
the supernatant (1.0mL), which was incubated for 1h
with intermittent shaking. Ice-cold 20% aqueous TCA
solution (5mL) was added and the mixture incubated for
15min. The precipited protein was washed three times
with ethanol-ethyl acetate (1:1), then dissolved in 1mL
of a solution containing 6M guanidine-HCl in 20mM
potassium phosphate (monobasic) adjusted to pH 2.3 with
TFA. After centrifuging,the absorbance of the supernatant
was read at 362nm (C =2.2 × 104M−1cm−1)
2.13. Measurement of Protein Content. The protein content
was determined by the Bradford method using BSA as the
standard [26].
2.14. Mucin Assay. Following a reported method [27], the
free mucin in the gastric tissues was estimated. Brieﬂy, the
glandular portion of the stomach was separated from the
lumenofthestomach,weighed,andtransferredimmediately
to 10mL of 0.1% w/v Alcian Blue (AB) solution (in 160mM
sucrose solution buﬀered with 0.05mM sodium acetate
solution,pHadjustedto5.8).Afterstainingfor2h,theexcess
dyewasremovedfromthetissuebytwosuccessiverinseswith
10mL of 250mM sucrose solution. The dye complexed with
the gastric wall mucus was extracted with 10mL of 500mM6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀect of eAE at diﬀerent doses (40mg/kg, 60mg/kg, and
120mg/kg) on tissue mucin secretion in NSAID-induced ulcer. The
mucin content of gastric tissues was carried out spectrophotomet-
rically on 3rd day of ulcer, as described under Section 2.T h ev a l u e s
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Figure 4: Eﬀect of eAE at diﬀerent doses (40mg/kg,60mg/kg and
120mg/kg) on mucosal PGE2 synthesis in NSAID-induced ulcer.
The mucosal PGE2 synthesis was carried out colorimetrically on
3rd day of ulcer, as described under “Materials and Methods”. The
values are mean S.D. ± (n = 8). ∗P>. 05, ∗∗P<. 05, ∗∗∗P<. 01,
and ∗∗∗∗P< . 001.
magnesium chloride by intermittent shaking (1min) at 30-
min intervals for 2h. The blue extract (2mL) was vigorously
shaken with an equal volume of diethyl ether. The resulting
emulsion was centrifuged at 3600rpm for 10min, and the
absorbance of the aqueous layer was read at 580nm. The
quantity of AB extracted per gram of wet glandular tissue
was calculated from a standard curve prepared using various
concentrations of AB.
2.15. PGE2 Assay. Following harvesting of the stomach,
the corpus (full thickness) was excised, weighed (100mg),
and suspended in 10mM sodium phosphate buﬀer, pH 7.4
(1ml). The tissues were ﬁnely minced and incubated at 37
◦C
for 20min. After centrifugation (9000 × g), the PGE2 levels
in the supernatant were measured by ELISA, following the
Prostaglandin E2 EIA kit (Cayman Chemical) instructions.
2.16. Estimation of Tissue Cytokine Levels. The TNF-α,I L -
1β, and IL-10 levels in the tissue homogenate were estimated
using commercially available ELISA kits, following the
manufacturer’s protocol.
The glandular part of the gastric mucosa after being
washed with PBS containing protease inhibitors was minced
and homogenized in a lysis buﬀer (10mM Tris-HCl pH 8.0,
150mM NaCl,1% Triton X-100,1mL) containing leupeptin
(2μg/mL) and PMSF (0.4μM). Following centrifugation at
15,000×gf o r3 0m i na t4 ◦C, the supernatant was collected
and cytokines levels were measured.
The samples along with the standards were seeded to
each well at an appropriate dilution and incubated at room
temperature for 90min. The wells were washed (5 times),
diluted polyclonal antibody (100μL) was added, and the
mixture was incubated further for 2h at room temperature.
Thewellswerewashedandincubatedfor2hafteradditionof
HRPOconjugate(100μL)secondaryantibody.Aftertheﬁnal
wash, TMB (100μL) was added to each well, the mixture was
incubated for 15min, the reaction was stopped by 1N HCl,
and the absorbance at 450nm was read.
2.17. Toxicity Test. Toxicity tests were carried out for the
subjecteddose60mg/kgandahigherdose300mg/kgofamla
in compared to sham-treated group for a period of 1 month.
The levels of serum bilirubin, albumin, aspartate amino-
transferase, alanine aminotransferase, blood urea nitrogen,
and creatine kinase were measured using commercially
available assay kits.
2.18. Statistical Analysis. Data are expressed as mean ±
S.D. unless mentioned otherwise. Comparisons were made
between diﬀerent treatments (ANOVA) using the software
GraphPad InStat (GraphPad Software Inc., San Diego, CA),
where an error protecting multiple comparison procedure,
namely Tukey-Kramer Multiple Comparison tests, was
applied for the analysis of signiﬁcance of all the data.
3. Results
3.1. Antioxidative Potential Encouraged to Select Amla Extract.
IC50 values (μg/mL) of test samples in scavenging DPPH
radicals revealed that ethanolic amla extract (eAE) exerted
50% (P<. 01) and 80.86% (P<. 001) better antioxidative
properties compared with methanolic (mAE) and hot water
(hAE) amla extract, respectively (Table 1). Therefore, eAE
was chosen for the evaluation of its antiulcerogenic propertyEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀect of eAE at diﬀerent doses (40mg/kg,60 and 120mg/kg) on tissue cytokines level in NSAID-induced ulcer. Tissue TNF-α (a),
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on NSAID-induced ulcerated mice. α-Tocopherol was used
as positive control.
3.2. eAE on NSAID-Induced Ulcer. Antioxidants could be
antiulcerous [28]. A study of ulcer index (UI) and MPO
activity showed dose-dependent biphasic eﬀect of eAE
(Tables 2 and 3), which was further validated by histological
study (Figure 1). A pick dose of 60mg/kg eAE induced
ulcer healing even at the third day of treatment, evidenced
by reduced UI and MPO activity in a dose-dependent
manner,thereafterwiththeincreaseofdosethehealingeﬀect
gradually decline. The dose of 40mg/kg b.w did not show
healing eﬀect possibly that dose is suboptimal to protect8 Evidence-Based Complementary and Alternative Medicine
Table 4 :e A Eo nl i v e rf u n c t i o nt e s t si nm i c e .
Groups
Parameters
Bilirubin
mg/ml Albumin g/dl SGOT SGPT IU/l ALP BUN mg/dl CK IU/l
Sham treated 0.098 ± 0.016 3.19 ± 0.16 199.7 ± 2.421 86.82± 17.22 319.86 ± 8.16 16.06 ± 2.61 118.36 ± 20.0
Ethanolic amla
extract (60mg/kg)
Treated
0.102 ± 0.012 3.25 ± 0.121 202.16 ± 2.984 85.01 ± 19.01 324.49 ± 5.94 18.72 ± 1.48 121.28 ± 17.69
Ethanolic Amla
extract (300mg/kg)
Treated
0.099 ± 0.026 3.23 ± 0.182 202.93 ± 2.004 89.862 ± 17.36 324.85 ± 5.76 15.49 ± 1.92 123.25 ± 16.51
n = 25; ± indicates S.D.SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; ALP, alkaline phosphatase; BUN,
Blood Urea Nitrogen; CK, Creatine Kinase.
the stomach from injury but at the dose of (≥80mg/kg),
however, eAE aggravated the NSAID-induced ulcerated
condition and delayed the healing process in a dose- and
time-dependent manner compared with ulcerated control
(Tables 2 and 3). These ulcerogenic biphasic properties of
eAE were also validated by the study of total stomach mucin
content (Figure 3). NSAID treatment signiﬁcantly reduced
mucin secretion at stomach compared with vehicle control,
but eAE at the dose of 60mg/kg induced mucin secretion
on the third day of treatment. Intriguingly, at the dose
of 40mg/kg and 120mg/kg eAE predominantly suppressed
mucin secretion, signiﬁcantly less compared with the sham
treated. As eAE showed signiﬁcant healing eﬀect on the third
day of treatment and biphasic ulcerogenic property was also
evident on that very day, further experimental study was
carried out on the third day only.
3.3. Oxidative Stress in Ulcer. Serum TAS (Figure 2(a))
and tissue total thiol (Figure 2(b)) content signiﬁed that
oxidative stress was noteworthy in NSAID-induced gastric-
ulcerated mice compared with vehicle control. On the third
day of treatment, although eAE reduced oxidative stress
at a dose of 60mg/kg, it provoked oxidative stress at the
dose of 40mg/kg and 120mg/kg, as further evidenced by
the oxidative stress marker MDA (Figure 2(c))a n dp r o t e i n
carbonyl (Figure 2(d)), which signiﬁed the oxidative injury
of tissue lipid and protein.
3.4. eAE on PGE2 Synthesis. NSAID-induced ulceration
suppressed PGE2 synthesis by 2.37-fold compared with
vehicle-treated control. ELISA data revealed that at a dose of
60mg/kg eAE induced PGE2 synthesis by 1.64-fold but at a
dose of 40mg/kg and 120mg/kg, eAE reduced the PGE2 level
1.06 fold and 1.21-fold compared with ulcerated untreated
mice (Figure 4), respectively.
3.5. eAE on Cytokines Expression. The balance of pro- and
anti-inﬂammatory cytokines modulates NSAID-induced
gastric ulceration. ELISA study showed that NSAID treat-
ment induced TNF-α (Figure 5(a))a n dI L - 1 β (Figure 5(b))
about 1.6- and 5.31-fold, respectively, compared with vehicle
control. However, eAE at a dose of 60mg/kg signiﬁcantly
reduced the level of inﬂammatory cytokines and induced
the level of IL-10 (Figure 5(c)) by 1.63-fold compared with
ulcerated untreated mice. However, treatment with eAE
at a dose of 40mg/kg and 120mg/kg drastically induced
inﬂammatory cytokine levels (TNF-α at 1.66 and 1.69-
and IL-1β at 3.26 and 3.73-fold) and suppressed the anti-
inﬂammatory cytokine level 2.29 and 2.32-fold compared
with the 60mg/kg dose of eAE respectively.
3.6. Antioxidant Property of eAE Modulated the Healing
Action. To evaluate whether the antioxidant property of eAE
exerted a healing eﬀect at a dose of 60mg/kg, mice were
pretreated with the glutathione S-transferase inhibitor BSO.
UI (Figure 6(a)) and MPO activity (Figure 6(b))w e r es i g -
niﬁcantly increased after BSO pretreatment compared with
the mice treated with 60mg/kg eAE, followed by depletion
of tissue PGE2 level (Figure 6(c)) and total thiol content
(Figure 6(d)). However, BSO pretreatment did not have any
impact on proinﬂammatory cytokine level (Supplementary
Data)butdrasticallyreducedtheanti-inﬂammatorycytokine
level (Figure 6(e)) compared with eAE, thus eliminating the
healing eﬀect of eAE.
3.7. Evaluation of Toxicity of eAE on Mice. Treatment with
eAE at a dose of 60mg/kg and 300mg/kg to their respective
group of mice for one month did not show any toxic side
eﬀect, as conﬁrmed by comparing the values with sham-
treated mice (Table 4).
4. Discussion
Antioxidants are known to augment the NSAID-induced
gastric ulcer healing process as NSAID-induced ulcer forma-
tion involves oxidative stress [29]. On this light, previously
we had been focused the cytoprotective nature of butanol
extract of the water fraction of amla fruit on NSAID-
induced ulcerated rats and reported that antioxidants are
predominantly responsible for the cyto protective action [8].
In present paper, we have tried to established that amla pos-
sesses signiniﬁcant healing property against indomethacin
induced stomach ulcers in mice at a biphasic manner onEvidence-Based Complementary and Alternative Medicine 9
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Inﬂammation
ROS
Body’s own
antioxidative
activity decreased
Hampered
prostaglandin
production
Mucosal
damage
NSAID (18mg/kg b.w) treatment
More production of ROS + Pro-/anti-
inﬂammatory cytokines imbalance
Amla (60mg/kg b.w)
Ulcer
Amla (40 and 120mg/kg b.w)
Mice survived
Body’s own
antioxidative
activity increased
Oxidative
stress
decreased
Oxidative
stress
increased
Ulcer healing
Death of mice
Bleeding
Acute toxicity
(a)
Normal
stomach
Amla treatment
Amla is good
for health
Improved body’s own oxidative
stress prevention power
(b)
Figure 7: (a) Depicted that NSAID treatment provoked oxidative stress as well as inﬂammatory response and hampared prostaglandin
production, resulting to formation of mucosal damage, ultimately ulcer. However, treatment of eAE at the dose of 60mg/kg b.w helped to
releasetheoxidativestresswhichinturnupregulatePGE2 status,IL-10level.Ontheotherhandtreatmentofamlaat40mg/kgand120mg/kg
b.w shows acute toxicity by provoking more ROS generation as well as imbalance pro/anti-inﬂammatory cytokines ratio. (b) Depicted that
amla is good for health and it has no toxic eﬀect in normal stomach at higher dose.
the basis of its antioxidative as well as immunomodulatory
properties.
The in vitro study depicted ethanolic extract of amla
as exerting the most antioxidative property compared with
othersolventextracts,asvalidatedbyDPPHscavengingassay
(Table 1). To evaluate the antiulcerogenic properties of eAE,
NSAID-induced ulcerated mice were orally administered
eAE once daily. Our microscopic examinations revealed that
administration of indomethacin caused marked mucosal
damage in the stomach within 6h of ulcer induction.
Maximum ulcerative damage was observed on the third
day after administration of indomethacin (Table 2). Mice
receiving only the vehicle showed no lesions in the gastric
mucosa. Indomethacin (18mg/kg) administration produced
typical time-dependent acute mucosal lesions in mice, as
assessed by histology (Figure 1). After seven days, however,
the autohealing was evident.
MPO activity, a marker of neutrophil aggregation at
the site of inﬂammation, is frequently increased under
ulcerated conditions and reduced with the healing process
[30]. Consistent with this, we also observed ulceration-
induced MPO activity up to the third day, followed by its
gradual reduction on the seventh day (Table 3).
At the same time, dose 120mg/kg eAE aggravated ulcera-
tion(Tables2and3)butatthedoseof40mg/kgdidnotshow
any healing eﬀect possibly that dose is suboptimal to protect
the stomach from injury. The UI results were well supported
by MPO activity data, where MPO activity was found to be
appreciable at doses of eAE (40mg/kg and 120 mg/ kg) even
on the seventh day compared with the ulcerated untreated
mice. This established a strong contraindication of eAE
use at its doses (40mg/kg and 120mg/kg) regarding gastric
ulceration induced by indomethacin in mice. However, eAE
at its standardized dose (60mg/kg) showed a signiﬁcant
healing eﬀect. The healing response was predominantly
evident from day 3. On day 7, eAE treatment (60mg/kg)
showed a better rate of healing compared with ulcerated
untreated mice (Table 3).
Amongst various factors, oxidative stress has been
implicated for the induction and pathogenesis of the
indomethacin-mediated gastroduodenal injury [31, 32].
Extensive research has proved that antioxidants might be
eﬀective not only in protecting against gastric mucosal
injury, but also inhibiting progression of gastric ulcer. This
leads oxidative damages to lipids, proteins, and the thiol-
dependent antioxidant defense systems [33, 34].
Experimental data clearly illustrated depletion of
total thiol (Figure 2(b)) in ulcerated untreated mice, which
was further validated by increased level of lipid peroxidation
by MDA (Figure 2(c)) and protein carbonyl (Figure 2(d)).
Nevertheless, the biphasic eﬀect of eAE were also evident
on manifestation of the oxidative stress markers. TreatmentEvidence-Based Complementary and Alternative Medicine 11
with eAE at a dose of 60mg/kg predominantly reduced MDA
and protein carbonyl level followed by a signiﬁcant increase
in total thiol, but exerted the opposite eﬀect at the doses of
40mg/ kg and 120mg/kg.
Compared to the individual oxidative markers, TAS assay
is based on the principle of inhibition of radical cation
productionbyantioxidants inthesample.Theconcentration
of antioxidant in the sample is inversely proportional to
the absorbance of the radical cation produced by 2,2-
azino-bis-(3-ethylbenzothiozoline-6-sulfonate) (ABTS) and
ferrylmyoglobin. Measurement of total antioxidant activity
in body ﬂuids is of important prognostic and diagnos-
tic value. The multiple defense system present in our
body against damaging free radicals is collectively called
antioxidants [35]. These antioxidants are present in the
blood and are measurable. As measurement of individual
component of the antioxidants is diﬃcult and time con-
suming, it is easier to measure total antioxidants present in
circulation.
Our results on the serum TAS level revealed severe oxida-
tive stress in gastric tissue of the indomethacin-administered
mice. Treatment with eAE at a dose of 60mg/kg signiﬁcantly
increase serum TAS level, but exerted the reverse eﬀect at the
doses of (40mg/kg and 120mg/kg) (Figure 2(a)).
This biphasic nature of eAE also had an impact on
immunological parameters. Stimulation of inﬂammatory
cytokines is extremely important in mucosal defense. One of
the most prominent modes of mediation of indomethacin-
induced gastropathy is the increased expression of the pro-
inﬂammatory cytokines [32, 36], as well as reducing the
anti-inﬂammatory cytokines (IL-10) at the mucosal level.
These led to a cytokine imbalance, which also correlate
with the extent of ulceration. In ulcerated untreated mice,
proinﬂammatory cytokine level increased signiﬁcantly com-
pared with the vehicle-treated group and simultaneously
the anti-inﬂammatory cytokine level was repressed consid-
erably (Figure 5). However, eAE treatment modulated the
pro- and anti-inﬂammatory cytokine levels at a dose of
60mg/kg. At this dose it reduced proinﬂammatory cytokines
(TNF-α and IL-1β) and concurrently induced the level
of tissue IL-10, thus exerting its healing eﬀect. On the
other hand, at a dose of 40mg/kg as well as 120mg/kg
eAE reversed the cytokine balance to the proinﬂammatory
end and thus once more proved the biphasic eﬀect of
eAE.
As NSAID act as nonspeciﬁc cyclooxygenase (COX)
blockers, treatment of NSAID-depleted tissue PGE2 level
(Figure 4). ELISA data showed that eAE treatment induced
tissue PGE2 level at a dose of 60mg/kg, thus augmenting the
healing process, but at a dose of 40mg/ kg and 120mg/kg
PGE2 level was drastically reduced to 42.404% (P<. 01)
and 49.88% (P<. 01) compared with the standardized dose
(60mg/kg) eﬀect, respectively.
As eAE was screened on the basis of its antioxidative
properties and treatment of eAE at a dose of 60mg/kg
markedly increased the total thiol level, we tried to delineate
whether eAE-induced ulcer healing was modulated by its
antioxidative property. To explore this issue, mice were
intraperitonially injected with the glutathione S-transferase
inhibitor BSO twice daily (see Section 2)b e f o r ee A E
treatment and further diﬀerent healing parameters were
measured. The role of endogenous sulphydryl compounds
in mucosal protection has been demonstrated previously in
ethanol induced gastric injury, in which the development
of damage was accompanied by a decrease in mucosal sul-
phydryl compounds [37]. Sulphydryl compounds scavenge
free radicals produced following tissue injury. BSO pre-
treatment predominantly hindered the healing eﬀect of eAE
(60mg/kg) as substantiated by increased UI (Figure 6(a))
and MPO (Figure 6(b)) activity followed by signiﬁcant
suppression of PGE2 synthesis (Figure 6(c)). Further, its
eﬀect were also evaluated on cytokine levels where BSO
pretreatment signiﬁcantly repressed the IL-10 level while
TNF-α and IL-1β concentration remained unchanged. This
signiﬁed that although eAE treatment reduced inﬂammatory
cytokine levels, the inhibitor study showed that tissue
IL-10 level played a key immunomodulatory role for the
augmentation of eAE-induced ulcer healing (Figure 6(e)).
Concurrently, BSO pretreatment reduced the tissue thiol
content (Figure 6(d)) compared with eAE-treated mice,
signifying that eAE treatment drove augmented gastric ulcer
healing through its antioxidative eﬀect.
Therefore, it can be concluded that eAE can exert
pronounced healing eﬀect on NSAID-induced gastric ulcer
on the basis of its antioxidant properties. Its healing eﬀect,
however, could be reversed to the ulcerogenic eﬀect in a
dose-speciﬁc manner, thus proving its biphasic action as well
(Figure 7(a)). But amla, itself has no side eﬀects even at its
higher dose (Figure 7(b)). We evaluated the possible toxic
eﬀectofamlaatthed osesof60mg/kgand300mg/kginmic e
(Table 4). The results suggested that amla given at this higher
dose does not have any side eﬀects in mice.
Appendix
NSAID: Nonsteroidal anti-inﬂammatory drug,
ROS: Reactive oxygen species,
PG: Prostaglandin,
BSO: Buthionine sulfoxamine,
eAE: ethanolic amla extract,
TAS: Total antioxidant status,
ELISA: Enzyme-linked immunosorbent assay,
GSH: Reduced glutathione,
IL: Interleukin,
TNF: Tumor necrosis factor.
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